2 results match your criteria: "Clamart. Univ. Paris-Sud[Affiliation]"
Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.
Clin Infect Dis
November 2014
CESP INSERM U1018 - Univ Paris-Sud, Le Kremlin-Bicetre Univ Paris-Sud AP-HP Hôpital Bicetre, Paris, France.
Article Synopsis
- Maternal immune health, specifically measured by CD4 cell count during pregnancy, is linked to the higher risk of serious infections in HIV-exposed but uninfected (HEU) infants.
- In a study involving nearly 7,640 HEU neonates, 699 experienced at least one serious infection within their first year, with notable increases in bacterial infections tied to lower maternal CD4 counts.
- The results suggest a targeted risk for serious infections from encapsulated bacteria in these infants, while serious viral infections were not influenced by maternal CD4 levels.
[Ten years' experience of preimplantation genetic diagnosis in Paris: remaining obstacles and potential solutions].
Bull Acad Natl Med
April 2012
Gynécologie-Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, Clamart. Univ. Paris-Sud, Clamart, INSERM, U782, Clamart, F-92140.
Preimplantation genetic diagnosis (PGD) has been authorized in France since 1999. Encouraging results have been obtained during the past 10 years in our Paris center, where 832 patients have undergone 1056 IVF-PGD procedures. With the advent of new techniques for the identification of genetic disease markers, our center can now offer PGD procedures for aneuploidy and 75 single-gene diseases.
View Article and Find Full Text PDF